GENT — Gentian Diagnostics ASA Cashflow Statement
0.000.00%
Last trade - 00:00- NOK595.30m
- NOK508.82m
- NOK176.50m
Annual cashflow statement for Gentian Diagnostics ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -24.8 | -23.6 | -10.6 | 20.1 | 25.7 |
| Depreciation | |||||
| Non-Cash Items | 4.63 | 3.35 | 8.62 | 2.58 | 3.31 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -14.2 | -3.93 | 7.92 | -18.1 | 4.5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -27.1 | -14 | 15.5 | 13.5 | 42.6 |
| Capital Expenditures | -12.8 | -14.7 | -4.49 | -10.9 | -10.8 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | 0 | -0.39 | — | — |
| Purchase of Investments | |||||
| Cash from Investing Activities | -12.8 | -14.7 | -4.88 | -10.9 | -10.8 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -3.12 | -4.33 | -4.6 | -4.95 | -11.1 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -43 | -33.3 | 6.04 | -2.9 | 21.2 |